EAU 2021 | miR-371a-3p microRNA panel alone is sufficient for diagnosis and monitoring

Matthew Murray, MB, BChir, PhD, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK, gives an overview of a study analyzing the four available circulating microRNA panels for the diagnosis of testicular germ cell tumors. Dr Murray reports that the miR-371a-3p panel was sufficient for diagnosis and monitoring, and comments on the implications of this finding for clinical practice. This interview took place at the virtual European Association of Urology (EAU) Virtual Meeting 2021.